These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. Akbar A; Yiangou Y; Facer P; Brydon WG; Walters JR; Anand P; Ghosh S Gut; 2010 Jun; 59(6):767-74. PubMed ID: 20551462 [TBL] [Abstract][Full Text] [Related]
5. Mucosal transcriptomics implicates under expression of BRINP3 in the pathogenesis of ulcerative colitis. Smith PJ; Levine AP; Dunne J; Guilhamon P; Turmaine M; Sewell GW; OʼShea NR; Vega R; Paterson JC; Oukrif D; Beck S; Bloom SL; Novelli M; Rodriguez-Justo M; Smith AM; Segal AW Inflamm Bowel Dis; 2014 Oct; 20(10):1802-12. PubMed ID: 25171508 [TBL] [Abstract][Full Text] [Related]
6. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Akbar A; Yiangou Y; Facer P; Walters JR; Anand P; Ghosh S Gut; 2008 Jul; 57(7):923-9. PubMed ID: 18252749 [TBL] [Abstract][Full Text] [Related]
7. Depression and mucosal proinflammatory cytokines are associated in patients with ulcerative colitis and pouchitis - A pilot study. Häuser W; Schmidt C; Stallmach A J Crohns Colitis; 2011 Aug; 5(4):350-3. PubMed ID: 21683306 [TBL] [Abstract][Full Text] [Related]
9. Molecular patterns in human ulcerative colitis and correlation with response to infliximab. Halloran B; Chang J; Shih DQ; McGovern D; Famulski K; Evaschesen C; Fedorak RN; Thiesen A; Targan S; Halloran PF Inflamm Bowel Dis; 2014 Dec; 20(12):2353-63. PubMed ID: 25397893 [TBL] [Abstract][Full Text] [Related]
10. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines. Wang ZL; Wang YD; Wang K; Li JA; Li L Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340 [TBL] [Abstract][Full Text] [Related]
13. Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation? Keszthelyi D; Troost FJ; Jonkers DM; Helyes Z; Hamer HM; Ludidi S; Vanhoutvin S; Venema K; Dekker J; Szolcsányi J; Masclee AA Eur J Pain; 2013 Oct; 17(9):1299-306. PubMed ID: 23529955 [TBL] [Abstract][Full Text] [Related]
14. The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis. Ceyhan GO; Bergmann F; Kadihasanoglu M; Erkan M; Park W; Hinz U; Giese T; Müller MW; Büchler MW; Giese NA; Friess H Gut; 2007 Apr; 56(4):534-44. PubMed ID: 17047099 [TBL] [Abstract][Full Text] [Related]
15. Interventions for the management of abdominal pain in ulcerative colitis. Sinopoulou V; Gordon M; Dovey TM; Akobeng AK Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013589. PubMed ID: 34291816 [TBL] [Abstract][Full Text] [Related]
16. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis. Koch Hansen L; Sevelsted-Møller L; Rabjerg M; Larsen D; Hansen TP; Klinge L; Wulff H; Knudsen T; Kjeldsen J; Köhler R J Crohns Colitis; 2014 Nov; 8(11):1378-91. PubMed ID: 24793818 [TBL] [Abstract][Full Text] [Related]
17. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease. Tang R; Yang G; Zhang S; Wu C; Chen M Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103 [TBL] [Abstract][Full Text] [Related]
18. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission. Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374 [TBL] [Abstract][Full Text] [Related]
19. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients. Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889 [TBL] [Abstract][Full Text] [Related]
20. Anhedonia in irritable bowel syndrome and in inflammatory bowel diseases and its relationship with abdominal pain. Carpinelli L; Bucci C; Santonicola A; Zingone F; Ciacci C; Iovino P Neurogastroenterol Motil; 2019 Mar; 31(3):e13531. PubMed ID: 30628137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]